HT3 A FRAMEWORK FOR DERIVING A MINIMALLY ACCEPTABLE TARGET CLINICAL PROFILE AND A MAXIMUM VALUE-BASED PRICE FOR DRUGS IN DEVELOPMENT TO MEET HEALTH TECHNOLOGY ASSESSMENT REQUIREMENTS
- Resource Type
- Abstract
- Source
- In
Value in Health 2009 12(3):A11-A12 - Subject
ISPOR FOURTEENTH ANNUAL INTERNATIONAL MEETING RESEARCH ABSTRACTS RESEARCH PODIUM ABSTRACTS - Language
- ISSN
- 1098-3015